These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33667783)

  • 1. Barriers to accessing opioid substitution treatment for opioid use disorder: A systematic review from the client perspective.
    Hall NY; Le L; Majmudar I; Mihalopoulos C
    Drug Alcohol Depend; 2021 Apr; 221():108651. PubMed ID: 33667783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.
    Larney S; Zador D; Sindicich N; Dolan K
    Drug Alcohol Rev; 2017 May; 36(3):305-310. PubMed ID: 27325289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for acceptance of a long-acting opiate substitution treatment studied through social representations and internalized stigma.
    Lacroix A; Puybaret V; Villéger P; Zattoni-Leroy J; Cantaloube S; Chevalier C; Nubukpo P
    Therapie; 2024; 79(3):307-317. PubMed ID: 37625937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study.
    Garpenhag L; Dahlman D
    Subst Abuse Treat Prev Policy; 2021 Oct; 16(1):81. PubMed ID: 34702338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol.
    Sanger N; Bhatt M; Zielinski L; Sanger S; Shahid H; Bantoto B; Samaan MC; de Souza R; Samaan Z
    Syst Rev; 2018 Jan; 7(1):16. PubMed ID: 29368662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.
    Couch JV; Whitcomb M; Buchheit BM; Dorr DA; Malinoski DJ; Korthuis PT; Ono SS; Levander XA
    Harm Reduct J; 2024 Jun; 21(1):125. PubMed ID: 38937779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to opioid use disorder treatment: A comparison of self-reported information from social media with barriers found in literature.
    Bremer W; Plaisance K; Walker D; Bonn M; Love JS; Perrone J; Sarker A
    Front Public Health; 2023; 11():1141093. PubMed ID: 37151596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opioid substitution therapy: Lowering the treatment thresholds.
    Kourounis G; Richards BD; Kyprianou E; Symeonidou E; Malliori MM; Samartzis L
    Drug Alcohol Depend; 2016 Apr; 161():1-8. PubMed ID: 26832931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthcare seeking among Swedish patients in opioid substitution treatment - a mixed methods study on barriers and facilitators.
    Troberg K; Lundqvist K; Hansson H; Håkansson A; Dahlman D
    Subst Abuse Treat Prev Policy; 2022 Feb; 17(1):8. PubMed ID: 35123518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceived barriers to methadone maintenance treatment among Iranian opioid users.
    Khazaee-Pool M; Moeeni M; Ponnet K; Fallahi A; Jahangiri L; Pashaei T
    Int J Equity Health; 2018 Jun; 17(1):75. PubMed ID: 29890990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.
    Miles J; Howell J; Sheridan D; Braucht G; Mericle A
    Am J Drug Alcohol Abuse; 2020 May; 46(3):266-272. PubMed ID: 32091262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported pathways to opioid use disorders and pain-related barriers to treatment engagement.
    Stumbo SP; Yarborough BJ; McCarty D; Weisner C; Green CA
    J Subst Abuse Treat; 2017 Feb; 73():47-54. PubMed ID: 28017184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is opioid substitution treatment beneficial if injecting behaviour continues?
    Gjersing L; Bretteville-Jensen AL
    Drug Alcohol Depend; 2013 Nov; 133(1):121-6. PubMed ID: 23773951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring the importance of different barriers to opioid agonist treatment using best-worst scaling in an Australian setting.
    Hall NY; Le L; Abimanyi-Ochom J; Mihalopoulos C
    Health Policy; 2023 Dec; 138():104939. PubMed ID: 37949002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: an international systematic review.
    Feelemyer JP; Jarlais DCD; Arasteh K; Phillips BW; Hagan H
    Drug Alcohol Depend; 2014 Jan; 134():251-258. PubMed ID: 24200104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services.
    Day E; Copello A; Seddon JL; Christie M; Bamber D; Powell C; Bennett C; Akhtar S; George S; Ball A; Frew E; Goranitis I; Freemantle N
    BMC Psychiatry; 2018 Jan; 18(1):8. PubMed ID: 29334921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder.
    Kotha A; Chen BA; Lewis L; Dunn S; Himes KP; Krans EE
    Contraception; 2019 Jan; 99(1):36-41. PubMed ID: 30114393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.